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ABSTRACT 
 
Testis Cancer (TC) is the most common cancer in 15-39 year-old men and with the white Caucasian race. This 
cancer consists of 0.7 percent of men’s cancer all over the world. The aim of this study is to investigate the 
relationship between the Age-Standardised Incidence Rates (ASIR) and Age-Standardised Mortality Rates (ASMR) 
of TC with Human Development Index (HDI) and its components at the European countries in 2012. This study was 
an ecologic study in European countries for assessment the correlation between ASIR and ASMR with HDI and its 
details including: Life expectancy at birth, Mean years of schooling and Gross National Income (GNI) per capita. 
We use correlation bivariate method for assessment the correlation between SIR and SMR with HDI and its 
components. Data of study was analyzed by SPSS15statistical analysis software; the significance level of the tests 
was considered P˂0.05. The results of the data investigation showed that the maximum ASIR of TC was observed 
respectively in the countries of Norway, Switzerland, and Denmark. Moreover findings showed the highest ASMR 
was in the countries of Hungary, Bulgaria and FYR Macedonia. The ASIR was positively correlated with HDI equal 
to 0.623(p≤0.001), with Life expectancy at birth equal to 0.602(p≤0.001), with the average years of schooling equal 
to 0.339(p=0.032) and with country’s Gross National Income (GNI) per capita equal to 0.466(p=0.002).The ASMR 
was negatively correlated with HDI equal to 0.537(p≤0.001), life expectancy at birth equal to 
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0.598(p≤0.001),average years of schooling equal to 0.107(p=0.510) and with counter’s GNI per capita equal to 
0.521(p≤0.001). Data from this study shows importance of using HDI and its components as relative factor on the 
ASIR and ASMR of TC. 
 
Keywords: Testis Cancer, HDI, Correlation, Incidence, Mortality, Europe.  
_____________________________________________________________________________________________ 
 
INTRODUCTION 
 
Testis Cancer (TC) is the most common cancer in 15-39 years-old men with the white Caucasian race. This cancer 
consists 0.7 percent of men’s cancer all over the world [1]. In western societies the TC is the agent of 1-1.5 percent 
of men’s cancer and 5 percent of all urinary tract cancer; the annual incidence rate of TC in these societies is equal 
to 3-6 new cases per 100,000 person at risk[2]. The incidence rate of TC in the past 50 years in the worldwide has 
increased trend, [3]. So that the number of new cases of TC in the world in 2008 is more than 52000 cases [4]; in 
2012 it is estimated 55,000 cases [1]. The largest increase in the incidence of TC was observed in Caucasian white 
race while the lowest rate of TC was observed in non-white races [5]. So, the highest incidence of TC has occurred 
in the west (8.7) and northern Europe (7.2) and the lowest incidence has occurred in Asian and Africa (less than 1) 
in 2012 [3]. Among European countries there is a 7 times difference in the incidence rate of TC [6]. The mortality 
rate from TC in the past 50 years has decreased in developed countries such as Denmark [7], England, wales [8] and 
Scotland [9]. But the reduction in the mortality rate of TC is not observed in the countries of west, central and east 
Europe [10]. In addition, significant differences can be seen in ASIR for TC among white Caucasian race and non-
white [11-13]. The prognosis of TC in the late1970 has been much improved by increasing the survival rate of 
patients to 90-95 percent [14]. As a result, from the 10,000 TC deaths in the word in 2012, only 2200 deaths 
occurred in advanced areas.  
 
In the last 30 years, numerous studies have been conducted to identify the risk factors for TC [15]. One of these risk 
factors is socioeconomic status (SES) [16]. Most of the studies that have examined the relationship between SES 
and TC have used social category and education as indicators of SES [15]. In these studies, various results were 
observed regarding the association among SES and morbidity and mortality from TC [17]. For example, in a study 
conducted in Finland, a significant relationship has been observed between the high socioeconomic level and TC 
[18], while in the studies conducted in America and Denmark; no relationship was seen [19-21]. Also, in the studies 
in other regions of the world inverse relationship was observed [22, 23]. According to our information, no study has 
been done still about the relationship between the ASIR and ASMR of TC with HDI and its two components 
including: life expectancy at birth and the country’s level of income per one person in European countries. Therefore 
in this study, the relationship between the ASIR and ASMR of TC with HDI and its components including: Life 
expectancy at birth, the average years of schooling, and the country’s (GNI) per capita in European countries in 
2012 has been investigated. We used GLOBOCAN data and the human development reports. Also, in the study 
human development index was used as an indicator of socio-economic development [24]. 
 
MATERIALS AND METHODS 
 
This study was an ecologic study in European countries for appraisal the correlation among age-specific incidence 
rate (ASIR) and age-specific mortality rate (ASMR) with Human Development Index (HDI) and its details 
including: Life expectancy at birth, average years of schooling and Gross National Income (GNI) per capita. Data 
about the ASIR and ASMR for every European countries for year 2012 had gathered from global cancer project that 
is available in (http://globocan.iarc.fr/Default. aspx)[25], and Human Development Index (HDI) from Human 
Development Report 2013 which include information about HDI and its details for every country in the word for 
year 2012 [26]. 
 
Method of estimate the age-specific Incidence and mortality rates in global cancer project by international agency 
for research on cancer  
 
Age-specific incidence rate (ASIR)  
The methods of estimation are country specific and the quality of the estimation depends upon the quality and on the 
amount of the available information for each country. In the theory, there are as many methods as countries, and 
because of the variety and the complexity of these methods, an overall quality score for the incidence and mortality 
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estimates combined which is almost impossible to establish. However an alphanumeric scoring system which 
independently describes the availability of incidence and mortality data has been established at the country level. 
The combined score is presented both with the estimation for each country with an aim of providing a broad 
indication of the robustness of the estimation.  
 
The methods for estimating the sex and ASIR of cancer for a specific country fall into one of the following broad 
categories, in priority order:  
 
1- Rates projected to 2012 (38 countries)-2- Most recent rates applied to 2012 population (20 countries)- 3-
Estimated from national mortality by modelling, which uses incidence mortality ratios derived from recorded data in 
country-specific cancer registries (13 countries)-4- Estimated from national mortality estimated by modeling which 
uses incidence mortality ratios derived from recorded data in local cancer registries in neighboring countries (9 
European countries)-5-Estimated from national mortality estimates that uses survival models(32 countries)-6- 
Estimated as the weighted average of the local rates (16 countries)-7- One cancer registry covering part of a country 
is used as representative of the country profile (11 countries)-8-Age/sex specific rates for “all cancers” were 
partitioned using data on relative frequency of different cancers (by age and sex) (12 countries-(9)-The rates are 
those of neighbore countries or registries in the same area (33 countries) [1,27,28]. 
 
Age-specific mortality rate (ASMR)  
Depending on the degree of details and accuracy of the national mortality data, six methods have been utilized in the 
following order of priority: 1-Rates projected to 2012 (69 countries)-2- Most recent rates applied to 2012 population 
(26 countries)-3- Estimated as the weighted average of regional rates (1 country)-4- Estimated from national 
incidence which estimates by modelling, and country-specific survival (2 countries)-5-Estimated from national 
incidence that estimates by using survival models (83 countries)-6-The rates are those of neighboring countries or 
registries in the same area (3 countries)[1,28,29]. 
 
Human development index (HDI)  
Human Development Index (HDI) is a composite measure of indicators along three dimensions including: life 
expectancy, educational attainment and command over the resources needed for a decent living. All groups and 
regions have seen notable improvement in all HDI components, with faster progress in low and medium HDI 
countries. Nevertheless, national averages hide large variations in human experience. Wide disparities which remain 
within countries of both the North and the South, and income inequality within and between many countries has 
been rising [26]. 
 
Ethical issues  
The research followed the tenets of the Declaration of Helsinki.  
 
Statistical analysis 
 In this study, we used the bivariate correlation method for assessment. We calculated the correlation between ASIR 
and ASMR with HDI and its details that include Life expectancy at birth, Mean years of schooling and Gross 
National Income (GNI) per capita. Statistical significance was assumed by P<0.05. All reported P-values are two-
sided. Statistical analyses were performed using SPSS (Version 15.0, SPSS Inc.). 
 
RESULTS 
 
Overall in 2012, European countries have recorded 21548 new cases of TC, in that the 5 countries with the highest 
number of cases are as follow: Germany with 4031 cases, Italy with 2664 cases, France (metropolitan) with 2332 
cases, the united kingdom with 20163 cases, Russian federation with 1330 cases, that these five countries totally 
have allocated 12520 cases (58.14%) of new cases of TC to themselves. 
 
 
 
 
 
 
 
Abdollah Mohammadian-Hafshejani et al Int J Med Res Health Sci. 2016, 5(9S):507-517  
______________________________________________________________________________ 
510 
Table1. Number, crude, and ASIR of TC in European countries in 2012 
 
Testis - Estimated incidence, all ages Testis - Estimated mortality, all ages 
Population Numbers Crude Rate ASR (W) Population Numbers Crude Rate ASR (W) 
Norway 313 12.6 12.2 Bulgaria 41 1.1 0.9 
Switzerland 453 11.9 12.1 Hungary 50 1.1 0.9 
Denmark 336 12.1 11.9 FYR Macedonia 10 1.0 0.8 
Hungary 566 12.0 10.9 Belarus 41 0.9 0.7 
Slovenia 111 11.1 10.8 Croatia 18 0.9 0.7 
Germany 4031 10.0 9.7 Bosnia Herzegovina 15 0.8 0.7 
Slovakia 284 10.7 9.3 Serbia 39 0.8 0.7 
Ireland 216 9.4 9.3 Slovakia 18 0.7 0.6 
Croatia 194 9.2 8.8 Ukraine 133 0.6 0.5 
The Netherlands 709 8.5 8.7 Poland 116 0.6 0.5 
Italy 2664 8.9 8.7 Republic of Moldova 10 0.6 0.5 
Czech Republic 496 9.6 8.6 Russian Federation 399 0.6 0.5 
Luxembourg 22 8.4 8.2 Slovenia 5 0.5 0.5 
Austria 368 8.9 8.2 Estonia 3 0.5 0.5 
France (metropolitan) 2332 7.5 7.6 Romania 63 0.6 0.5 
Iceland 12 7.3 7.2 Austria 25 0.6 0.5 
Sweden 329 6.9 7.0 Czech Republic 30 0.6 0.4 
Malta 16 7.7 6.9 Latvia 6 0.6 0.4 
United Kingdom 2163 7.0 6.8 Switzerland 19 0.5 0.4 
Bulgaria 220 6.2 6.2 Greece 27 0.5 0.4 
Portugal 302 5.8 6.0 Denmark 11 0.4 0.3 
Belgium 300 5.7 5.8 Norway 12 0.5 0.3 
Finland 144 5.4 5.7 Albania 7 0.4 0.3 
Serbia 285 5.8 5.5 Cyprus 2 0.3 0.3 
Poland 939 5.1 4.7 The Netherlands 26 0.3 0.3 
Montenegro 14 4.5 4.6 Portugal 18 0.3 0.3 
Latvia 55 5.3 4.6 France (metropolitan) 98 0.3 0.3 
FYR Macedonia 51 4.9 4.4 Germany 146 0.4 0.3 
Albania 75 4.6 4.3 Lithuania 5 0.3 0.3 
Cyprus 28 4.9 4.2 Italy 82 0.3 0.2 
Estonia 23 3.7 3.5 Ireland 5 0.2 0.2 
Spain 823 3.6 3.5 Belgium 13 0.2 0.2 
Bosnia Herzegovina 59 3.3 3.0 United Kingdom 64 0.2 0.2 
Romania 340 3.3 2.9 Sweden 9 0.2 0.2 
Belarus 131 3.0 2.6 Spain 42 0.2 0.1 
Ukraine 570 2.8 2.5 Finland 4 0.2 0.1 
Greece 157 2.8 2.5 Iceland 0 0.0 0.0 
Lithuania 34 2.2 2.0 Montenegro 0 0.0 0.0 
Republic of Moldova 37 2.2 2.0 Luxembourg 0 0.0 0.0 
Russian Federation 1330 2.0 1.7 Malta 0 0.0 0.0 
 
Among European countries, five countries with the highest ASIR of the TC are as follow; Norway with 12.2 per 
100,000, Switzerland with 12.1 per 100,000, Denmark with 11.9 per 100,000, Hungary  with 10.9 per 100,000, and 
Slovenia with 10.8 per 100,000, respectively. Five countries with the lowest ASIR of the TC were Russian 
Federation with 1.7 per 100,000, Republic of Moldova with 2 per 100,000, Lithuania with 2 per 100,000, Ukraine 
with 2.5 per 100,000, and Greece with 2.5 per 100,000, respectively. The number, crude rates and ASIR of the TC in 
European countries based on sex are presented in Table 1. The countries with the highest and lowest ASIR in both 
sexes are observable in Table 1, Figure 1 and Map 1.  
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Map 1: Distribution of the ASIR of TC in European countries in 2012 
 
On the other hand in Europe countries in 2012, 1612 cases of deaths occurred due to TC, that among them the five 
countries with the highest number of death as are as follows; Russian federation with 399 cases, Germany with 146 
cases, Ukraine with 133 cases, Poland with 116 cases and France (metropolitan) with 98 cases, that these five 
countries totally have allocated 892 cases (55.33%) of death cases of TC to themselves.  
 
In European countries, the five countries with the highest ASMR from TC are as follows: Bulgaria with 0.9% per 
100,000, Hungary with 0.9% per 100,000, FYR Macedonia with 0.8% per 100,000, Serbia with 0.7% per 100,000 
and Croatia with 0.7% per 100,000, respectively. Similarly, the five countries with the lowest ASMR from TC are as 
follow: Malta, Luxembourg, Montenegro, ice land with ASMR that is equal to 0 and Finland with ASMR that is 
equal to 0.1 per 100,000 (Table and Figure number 1 and Map number 2).  
 
 
 
Map 2: Distribution of ASMR of TC in European countries in 2012 
 
In 2012, the number of 21548 new cases of TC were observed in the European countries, that the number of 20741 
cases(96.25%) are in the age group below 65 years old and 807 cases, (03.75%) are in the age group 65 years old 
and more. According to  the forecasts it is expected that in the years 2015,2020,2025,2030,2035 the number of new 
cases respectively be equal to 21175,20555,20091,19672,19206 which shows that over these years compared to the 
year 2012. The number of new cases of TC respectively reduced to 373, 993, 1457, 1876 and 2342 cases. In fact, 
over these years compared to the year 2012, the number of new cases respectively has been reduced to 1.73%, 
4.60%, 06.76%, 08.70% and 10.88%. Although, it is predicted that the number of new cases of TC has been reduced 
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between the years 2012 and 2035, but it is expected that this reduction will be more in the age group below 65 and 
in the age group 65 and more number of new cases will increases.  
 
Figure 1: ASIR and ASMR from TC in European countries in 2012 
 
Table 2: Estimated number of morbidity and mortality from TC in Europe in 2012-2035 
 
Year Age group Estimated number of new cancers Age group Estimated number of cancer deaths 
2012 
 
21548 
 
1612 
 
ages < 65 20741 ages < 65 1221 
 
ages >= 65 807 ages >= 65 391 
2015 
 
21175 
 
1619 
 
ages < 65 20316 ages < 65 1207 
 
ages >= 65 859 ages >= 65 412 
 
Demographic change -373 
 
7 
 
ages < 65 -425 ages < 65 -14 
 
ages >= 65 52 ages >= 65 21 
2020 
 
20555 
 
1623 
 
ages < 65 19616 ages < 65 1174 
 
ages >= 65 939 ages >= 65 449 
 
Demographic change -993 
 
11 
 
ages < 65 -1125 ages < 65 -47 
 
ages >= 65 132 ages >= 65 58 
2025 
 
20091 
 
1644 
 
ages < 65 19061 ages < 65 1149 
 
ages >= 65 1030 ages >= 65 495 
 
Demographic change -1457 
 
32 
 
ages < 65 -1680 ages < 65 -72 
 
ages >= 65 223 ages >= 65 104 
2030 
 
19672 
 
1666 
 
ages < 65 18545 ages < 65 1120 
 
ages >= 65 1127 ages >= 65 546 
 
Demographic change -1876 
 
54 
 
ages < 65 -2196 ages < 65 -101 
 
ages >= 65 320 ages >= 65 155 
2035 
 
19206 
 
1683 
 
ages < 65 18002 ages < 65 1092 
 
ages >= 65 1204 ages >= 65 591 
 
Demographic change -2342 
 
71 
 
ages < 65 -2739 ages < 65 -129 
 
ages >= 65 397 ages >= 65 200 
Population forecasts were extracted from the United Nations, World Population prospects, the 2012 revision. 
Numbers are computed using age-specific rates and corresponding populations for 10 age-groups. 
GLOBOCAN 2012 (IARC) - 15.3.2016 
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Also, in 2012, the number of 1612 cases of death were observed in European countries that among them 1221 
case(75.74%) were in the age group below 65 years and 391 cases, (24.26%) were in the age group 65 year and 
more. According to the forecasts it is expected that in the years 2015,2020,2025,2030 and 2035 the number of death 
cases respectively be equal to 1683,1666,1644,1623 and 1619 cases which shows that over these years compared to 
2012 the number of deaths from the disease respectively will reduce to 7,11,32,54,71 cases. Although it is expected 
that the number of deaths from TC reduces between 2012 and 2035, but it is expected that this reduction will be 
observed more in the age group below 65 and in the age group 65 and more number of deaths will increases.  
 
In the table number 3 the respective value of the HDI and its components has been shown for each of European 
countries that are arranged according to the HDI index. Thus in European countries in terms of HDI is classified as 
follows, so that 29 countries in the HDI classified in  very high category ,9 countries in high category and 2 
countries in the medium category. 
 
Table3. Human development index (HDI) in European countries in 2012 
 
HDI status POPULATION Human Development Index(HDI) 
Life expectancy 
at birth 
Mean Year of 
schooling 
Gross national income 
(GNI) per capita 
Very high human 
development 
Norway 0.955 81.3 12.6 48688 
The Netherlands 0.921 80.8 11.6 37282 
Germany 0.92 80.6 12.2 35431 
Ireland 0.916 80.7 11.6 28671 
Sweden 0.916 81.6 11.7 36143 
Switzerland 0.913 82.5 11 40527 
Iceland 0.906 81.9 10.4 29176 
Denmark 0.901 79 11.4 33518 
Belgium 0.897 80 10.9 33429 
Austria 0.895 81 10.8 36438 
France (metropolitan 0.893 81.7 10.6 30277 
Finland 0.892 80.1 10.3 32510 
Slovenia 0.892 79.5 11.7 23999 
Spain 0.885 81.6 10.4 25947 
Italy 0.881 82 10.1 26158 
Luxembourg 0.875 80.1 10.1 48285 
United Kingdom 0.875 80.1 9.4 32538 
Czech Republic 0.873 77.8 12.3 22067 
Greece 0.86 80 10.1 20511 
Cyprus 0.848 79.8 9.8 23825 
Malta 0.847 79.8 9.9 21184 
Estonia 0.846 75 12 17402 
Slovakia 0.84 75.6 11.6 19696 
Hungary 0.831 74.6 11.7 16088 
Poland 0.821 76.3 10 17776 
Lithuania 0.818 72.5 10.9 16858 
Portugal 0.816 79.7 7.7 19907 
Latvia 0.814 73.6 11.5 14724 
Croatia 0.805 76.8 9.8 15419 
High human 
development 
Belarus 0.793 70.6 11.51 13385 
Montenegro 0.791 74.8 10.5 10471 
Russian Federation 0.788 69.1 11.7 14461 
Romania 0.786 74.2 10.4 11011 
Bulgaria 0.782 73.6 10.6 11474 
Serbia 0.769 74.7 10.2 9533 
Albania 0.749 77.1 10.4 7822 
Ukraine 0.74 68.8 11.3 6428 
Bosnia Herzegovina 0.735 75.8 8.3 7713 
Medium human 
development 
Republic of Moldova 0.66 69.6 9.7 3319 
FYR Macedonia 0.59 69.6 5.6 3557 
 
ASIR and HDI 
Between the ASIR of TC and HDI is a positive correlation equal to 0.623, this relationship was statically significant 
(p≤0.001). Also between the components of the HDI and ASIR is a positive correlation. So that the ASIR with life 
expectancy in birth had positive correlation equal to 0.602(p≤0.001), with the average years of education had 
Abdollah Mohammadian-Hafshejani et al Int J Med Res Health Sci. 2016, 5(9S):507-517  
______________________________________________________________________________ 
514 
positive correlation equal to 0.339(p=0.032), and with GNI per capita had positive correlation equal to 
0.466(p=0.002) (figure 2). 
 
ASMR and HDI 
On the other hand between the ASMR of TC and HDI is a negative correlation equal to 0.537, this association was 
statistically significant (p≤0.001). Also between the components of the HDI and ASMR was a negative correlation, 
so that the ASMR with life expectancy at birth has a negative correlation equal to 0.598(p≤0.001), with the average 
years of education had a negative correlation equal to 0.107(p=0.510), and with GNI per capita had a negative 
correlation equal to 0.521(p≤0.001) (figure 3). 
 
 
Figure2: Correlation between HDI and ASIR of TC in European countries in 2012 
 
 
Figure3: Correlation between HDI and ASMR for TC in European countries in 2012 
 
DISCUSSION 
 
In the present study the relationship between the ASIR and ASMR of TC with HDI and its three components were 
examined in European countries in 2012. We found that between the ASIR of TC and HDI and its components was a 
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positive correlation and between the ASMR of TC and HDI and its components was a negative correlation .Also, it 
is anticipated that between 2012 and 2035, the number of new cases and the number of deaths from TC in the age 
group below 65 years has been declined and in the age group of 60 and more has been increased. 
 
According to our information no studies has been done about the relationship between the ASIR and ASMR of TC 
with HDI and its two components including: life expectancy at birth and country’s GNI per capita in European 
countries. But about the relationship between the incidence rate of TC and third component of HDI which is the 
average years of schooling across these countries, several studies have been conducted, the results of some of these 
studies showed the direct link between the risk of TC incidence and high levels of education. For example, in a 
study conducted by Rimpelä AH in 1987 in Finland, a direct relationship was observed between the ASIR of TC and 
high level of education [18]. Also, in a study conducted in England by Swerdlow and et al in a 1991, a direct 
relationship was observed between the risk of TC and the high level of education [16]. In another study conducted in 
Germany by Schmeisser in 2013, also the same results were observed [17]. This is while according to other studies 
conducted in other European countries no relationship was obseved between the incidence rate of TC and the level 
of education or even this relationship is inverse in some researches. So that in a study conducted in Denmark by 
Moller and et al, in 1996 there is no relationship between TC risk and level of education [21]. Similarly in another 
study conducted by Marså and et al in Denmark in 2008, also no relationship was observed between the incidence 
rate of TC and education level [20]. In another study conducted by Pukkala and et al in Finland in 2002, the reduced 
incidence rate of TC in people with high social class and increased incidence rate in people with low social class 
was observed [23]. 
 
In the present study, the probable cause of the observed direct correlation between the ASIR of TC with HDI and its 
components could be that in countries with higher levels of HDI, diagnostic and screening programs are done 
formally and with better facilities and equipment than those in the lower level of HDI. So in these countries, the 
likelihood of identifying and patients reporting is more. On the other hand the probable cause of the inverse 
relationship and reduced level of mortality with increase in HDI could be due to patient’s access to medical facilities 
and equipment’s and better care in these countries than countries with lower levels of HDI. 
 
The limitation of this study was the observed differences in the ASIR and ASMR of TC in European countries 
which could be due to different quality of collection methods and data reporting, and also access to different 
methods of diagnosis and care among these countries. It  should also be noted that this study is an ecological study 
and its results can be interpret only at the population level and attribution of the results of this study to individual 
levels lead to occurrence of ecological fallacy. 
 
This study also has some advantages. The first advantage is that we studied all European countries. So the data have 
perfect integrity. The second advantage is that our findings showed the introduction of HDI and its components as 
risk factors for ASIR and ASMR of TC in European countries which can help determining the risk factors of this 
disease more. The third advantage is the novelty of findings because we couldn’t find a study that shows the 
relationship between the ASIR and ASMR of TC with HDI and its components. Accordingly, it is proposed that 
similar studies in other parts of the word should be done so that the relationship hypothesis between the incidence 
and mortality rate of TC and HDI in these regions can be examined. 
 
CONCLUSION 
 
According to the results of this study, between the ASIR of TC with HDI, life expectancy at birth, the average level 
of education and GNI per capita are positive correlation. Also, between ASMR of TC with HDI, life expectancy at 
birth, the average level of education and GNI per capita is a negative correlation. So the data from this study shows 
the importance of using HDI and its components as factors affecting the ASIR and ASMR of TC. 
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